In our previous blog, we examined a report from the United States Food and Drug Administration (FDA) which indicates faulty medical devices have played a role in 83,000 deaths and 1.7 million injuries worldwide in the last 10 years.

In that piece, we also looked at promises from the FDA to revise and improve the approval process for surgical implants and other medical technology.

The Scope of the Problem

According to Fortune Magazine, the FDA is poised to overhaul the current system used to approve surgical implants and medical devices before they are released to the market. The existing system—with few clinical trials and limited centrally held evidence—has failed to detect problems in many medical devices in circulation and led to many patient injuries.

For reference, the International Consortium of Investigative Journalists (ICIJ) has published a searchable database of 70,000 device notices, alerts, and recalls so patients can view the safety records of particular devices.

The Current System

The existing approval system depends heavily on a new device’s similarity to older, existing technology. An overhaul of the process will place a stronger emphasis on clinical testing.

With a new process in place, the FDA hopes to create “a more robust medical device safety net for patients through better data,” adding: “Unfortunately, the FDA cannot always know the full extent of the benefits and risks of a device before it reaches the market.”

The Intended Overhaul

Almost 20% of medical devices in current use are based on technology that is over 10 years old. With a revised approval process, the FDA hopes to encourage device manufacturers to develop emerging products based on technologies 10 years old or less—and may publish a list of medical devices based on older technologies in the name of consumer safety.

FDA authorities emphasize the need to incorporate new and better technology, hoping device makers can manufacture surgical implants and medical devices which are safer and more effective.

Graves McLain is Here to Help

If you or a loved one has been injured by a Dangerous Drug or Defective Medical Device, call Graves McLain right away at 918-359-6600 or fill out a free consultation form online. When you call one of our experienced Tulsa, Oklahoma Product Liability Attorneys, we will speak with you for FREE and determine the best course of action.

We review every detail of your situation at no cost to you—and fight hard to protect your rights.

Trust our team, we are here to help. At Graves McLain, you will never pay an attorney’s fee up front—and you owe us nothing until we win your case. At Graves McLain, we don’t get paid until you do.

Graves McLain, Serious Lawyers for Serious Injuries

When injury victims need a law firm with a reputation for excellence, turn to Graves McLain Injury Lawyers. We are a top-rated personal injury firm determined to be the best. With decades of award-winning representation, our clients recover the compensation they need to put their lives back together.

  • I knew my auto accident wouldn’t be worth much and they knew it too but worked as if it was a million dollar case and kept me informed hope I never need an attorney again but if I do it’ll be graves mcclain I brag on them to everyone

    Margie C

  • The staff is great and super friendly. They helped me get the money I deserved. I would definitely recommend them to everyone!

    CiCi H

  • My orthopedic doctor recommended Graves McLain Injury Lawyers, PLLC, to me following the need for revision hip surgery due to a hip from Stryker that was putting poison into my system. The doctor took care of the hip, and Graves McLain Injury Lawyers, PLLC, took care of the legal case. They were very thorough, professional, courteous, and always ready to answer the questions I had throughout the length of the case. In a word, the entire office is fantastic. I’m sure they were tired of my inquiries on the case’s progress, but they did not show it. They were always willing to respond and were very positive. If I ever have a claim in the future, they will be the first group to whom I reach out.

    Robert S.

Contact Our Firm &
Request a Free Case Review